- Filed
- Nov 6, 2014 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2014 · Oct 31, 2014 | 54.04M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2014 | 55.83M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2014 | 51.67M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2013 | 45.76M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2013 | 45.11M sh |
| Stock Repurchased | Q3 2014 · Sep 30, 2014 | $4.86M |
| Stock Repurchased | Q3 2014 · Sep 30, 2013 | $935K |
| Capex | Q3 2014 · Sep 30, 2014 | $24.68M |
| Capex | Q3 2014 · Sep 30, 2013 | $11.06M |
| Short Term Debt | Q3 2014 · Sep 30, 2014 | $4.85M |
| Short Term Debt | Q3 2014 · Dec 31, 2013 | $2M |
| Cash And Equivalents | Q3 2014 · Sep 30, 2014 | $141.12M |
| Cash And Equivalents | Q3 2014 · Dec 31, 2013 | $122.37M |
| Cash And Equivalents | Q3 2014 · Sep 30, 2013 | $145.72M |
| Cash And Equivalents | Q3 2014 · Dec 31, 2012 | $143.81M |
| Stockholders Equity | Q3 2014 · Sep 30, 2014 | $1.1B |
| Stockholders Equity | Q3 2014 · Dec 31, 2013 | $601.22M |
| Current Liabilities | Q3 2014 · Sep 30, 2014 | $174.05M |
| Current Liabilities | Q3 2014 · Dec 31, 2013 | $99.08M |
| Total Liabilities | Q3 2014 · Sep 30, 2014 | $1.14B |
| Total Liabilities | Q3 2014 · Dec 31, 2013 | $355.59M |
| Current Assets | Q3 2014 · Sep 30, 2014 | $336.45M |
| Current Assets | Q3 2014 · Dec 31, 2013 | $234.86M |
| Total Assets | Q3 2014 · Sep 30, 2014 | $2.24B |
| Total Assets | Q3 2014 · Dec 31, 2013 | $956.81M |
| Sga Expense | Q3 2014 · Sep 30, 2014 | $72.69M |
| Sga Expense | Q3 2014 · Sep 30, 2014 | $214.81M |
| Sga Expense | Q3 2014 · Dec 31, 2013 | $52.58M |
| Sga Expense | Q3 2014 · Dec 31, 2013 | $184.3M |
| Sga Expense restated | Q3 2014 · Sep 30, 2013 | $45.37M |
| Sga Expense restated | Q3 2014 · Sep 30, 2013 | $131.72M |
| Sga Expense | Q3 2014 · Dec 31, 2012 | $145.86M |
| Rd Expense | Q3 2014 · Sep 30, 2014 | $26.45M |
| Rd Expense | Q3 2014 · Sep 30, 2014 | $77.64M |
| Rd Expense | Q3 2014 · Dec 31, 2013 | $21.91M |
| Rd Expense | Q3 2014 · Dec 31, 2013 | $76.26M |
| Rd Expense restated | Q3 2014 · Sep 30, 2013 | $18.45M |
| Rd Expense restated | Q3 2014 · Sep 30, 2013 | $54.35M |
| Rd Expense | Q3 2014 · Dec 31, 2012 | $53.62M |
| Net Income | Q3 2014 · Sep 30, 2014 | $2.11M |
| Net Income | Q3 2014 · Sep 30, 2014 | −$10.91M |
| Net Income | Q3 2014 · Sep 30, 2013 | $5.8M |
| Net Income | Q3 2014 · Sep 30, 2013 | $9.6M |
| Operating Income | Q3 2014 · Sep 30, 2014 | $9.14M |
| Operating Income | Q3 2014 · Sep 30, 2014 | −$9.97M |
| Operating Income | Q3 2014 · Sep 30, 2013 | $6.91M |
| Operating Income | Q3 2014 · Sep 30, 2013 | $15.29M |
| Cost Of Revenue | Q3 2014 · Sep 30, 2014 | $125.25M |
| Cost Of Revenue | Q3 2014 · Sep 30, 2014 | $334.61M |
| Cost Of Revenue | Q3 2014 · Dec 31, 2013 | $55.86M |
| Cost Of Revenue | Q3 2014 · Dec 31, 2013 | $209.93M |
| Cost Of Revenue restated | Q3 2014 · Sep 30, 2013 | $53.86M |
| Cost Of Revenue restated | Q3 2014 · Sep 30, 2013 | $154.07M |
| Cost Of Revenue | Q3 2014 · Dec 31, 2012 | $175.47M |